Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
milestones
Biotech
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Biopharmas love to break the news of an M&A deal with a splashy number and added milestones. But how much of that is actually paid out in the end?
Annalee Armstrong
Oct 17, 2023 6:00am
AbbVie knocks down earnings forecast due to IPR&D charge
Apr 6, 2023 11:10am
Lilly, Entos team up to improve nucleic acid delivery
Jan 6, 2022 6:45am
Novimmune unit nabs Takeda milestone payment for hemophilia work
Feb 14, 2020 9:10am
Genentech joins immune tolerance field with Parvus hookup
May 17, 2019 8:20am
Arrowhead starts triple-combo HBV test, triggering J&J payday
Apr 24, 2019 10:44am
